Effects of membrane plasma exchange on the hemostatic system and on thyroid hormones in critically ill patients.
The present study examined the effects of repeated plasma exchanges with membrane filtration (Plasmaflux P2 membrane, 4.3 I human albumin solution) on the hemostatic system and on thyroid hormones in critically ill patients. Clotting factors V, VII, VIII, IX, X, XI, XII, XIII, fibrinogen, antithrombin III (ATIII), prothrombin time (PT), activated partial thromboplastin time (PTT), total (TT3) and free tri-iodothyronine (FT3), total (TT4) and free thyroxine (FT4), and thyroxine binding globulin (TBG) were determined before, immediately after, 1, 3, 6 and 24 h after plasma exchange in 6 patients (3 with glomerulonephritis, 2 with IgG myeloma, 1 with chronic polyneuritis) during 18 plasma exchanges. After plasma exchange levels of clotting factors and ATIII were markedly lowered but except for fibrinogen and factor XIII, they were not reduced by repeated exchange procedures. Thyroid hormones and TBG were reconstituted after 24 h. Pre-exchange levels, except for TT4 and TBG, were not lowered by repeated exchange procedures. Risk of bleeding or thrombosis is small and there is no appreciable risk of loss of thyroid hormones during repeated plasma exchanges.
D000328:Adult; D000368:Aged; D001779:Blood Coagulation Factors / Q000032:analysis / Q000502:physiology*; D005921:Glomerulonephritis / Q000097:blood / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000503:physiopathology / Q000628:therapy; D010951:Plasma Exchange; D011115:Polyneuropathies / Q000097:blood / Q000503:physiopathology / Q000628:therapy; D013963:Thyroid Hormones / Q000097:blood*
D001779:Blood Coagulation Factors; D013963:Thyroid Hormones